SYNGENE logo

Syngene International LTD

F&O
SYNGENE·NSE·
402.10 +1.35 (+0.34%)
Market Cap16198.84 Cr
PE Ratio32.61
Volume6,24,865
Day High - Low403.00 - 397.05
52W High-Low678.95 - 375.25
DocStoX Score
4.2/10
Weak
Fair Value
Sign in to see
ROE
10.09%
Average
P/E
32.61x
Fair
Debt / Equity
0.12
Low
Industry
Healthcare
Healthcare Research, Analytics & Technology
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day397.05
403.00
52W375.25
678.95
DocStoX take

Supported by risk (9.8), but held back by momentum (0.0). Risk looks strong at 9.8, but that is offset by momentum at 0.0 and growth at 1.8 and valuation at 1.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.2
/10
Weak
Quality
Solid
ROE 10.1%
Valuation
Expensive
P/E 32.6×
Growth
Flat
Revenue +9.4% 5Y CAGR
Risk
Low risk
D/E 0.12
Momentum
Weak
9% of 52-week range

At a glance

Market Cap
₹16,199 Cr
52W High / Low
₹679 / ₹375
Dividend Yield
0.30%
Promoter Holding
52.59%
EPS (TTM)
₹12.33
Book Value
₹115.26

Key highlights

  • Low leverage — D/E 0.12
  • Profitable in all of the last 5 years
  • Profit shrinking 6% a year
  • Valuation is weak (1.9/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Research, Analytics & Technology

SYNGENE INTERNATIONAL LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.